CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials

Trials

Volumn 11, Issue , 2010, Pages

  Schulz, Kenneth F ^a   Altman, Douglas G ^b   Moher, David ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL STUDY; EXPERIENCE; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INTERNET; METHODOLOGY; PARALLEL DESIGN; PRACTICE GUIDELINE; PUBLICATION; EVIDENCE BASED MEDICINE; HUMAN; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 77952279621     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-32     Document Type: Article

References (34)

1. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-6. 10.1136/bmj.323.7303.42, 1120670, 11440947.
2. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005, 365:1159-62. 10.1016/S0140-6736(05)71879-1, 15794971.
3. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews?. BMJ 2008, 336:1472-4. 10.1136/bmj.39590.732037.47, 18583680.
4. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008, 3:e3081. 10.1371/journal.pone.0003081, 2518111, 18769481.
5. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276:637-9. 10.1001/jama.276.8.637, 8773637.
6. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001, 357:1191-4. 10.1016/S0140-6736(00)04337-3, 11323066.
7. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001, 134:657-62.
8. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285:1987-91. 10.1001/jama.285.15.1987, 11308435.
9. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006, 185:263-7.
10. Hopewell S, Dutton S, Yu L-M, Chan A-W, Altman DG. The quality of reports of randomised trials in 2000 and 2006: a comparative study of articles indexed by PubMed. BMJ 2010, 340:c723. 10.1136/bmj.c723, 20332510.
11. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004, 328:702-8. 10.1136/bmj.328.7441.702, 381234, 15031246.
12. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006, 295:1152-60. 10.1001/jama.295.10.1152, 16522836.
13. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 20332511.
14. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-12. 10.1001/jama.273.5.408, 7823387.
15. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998, 352:609-13. 10.1016/S0140-6736(98)01085-X, 9746022.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, . for the PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551, for the PRISMA Group.
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, . Standards for Reporting of Diagnostic Accuracy Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003, 326:41-4. 10.1136/bmj.326.7379.41, 1124931, 12511463, Standards for Reporting of Diagnostic Accuracy.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, . for the STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007, 335:806-8. 10.1136/bmj.39335.541782.AD, 17947786, for the STROBE Initiative.
19. Standards of Reporting Trials Group A proposal for structured reporting of randomized controlled trials. JAMA 1994, 272:1926-31. 10.1001/jama.272.24.1926, 7990245, Standards of Reporting Trials Group.
20. Rennie D. Reporting randomized controlled trials. An experiment and a call for responses from readers. JAMA 1995, 273:1054-5. 10.1001/jama.273.13.1054, 7897791.
21. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF, . CONSORT Group CONSORT for reporting randomised trials in journal and conference abstracts. Lancet 2008, 371:281-3. 10.1016/S0140-6736(07)61835-2, 18221781, CONSORT Group.
22. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291:2457-65. 10.1001/jama.291.20.2457, 15161896.
23. Sackett DL. Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't?. Int J Epidemiol 2007, 36:664-5. 10.1093/ije/dym088, 17675306.
24. Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002, 359:696-700. 10.1016/S0140-6736(02)07816-9, 11879884.
25. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH. Randomized trials stopped early for benefit: a systematic review. JAMA 2005, 294:2203-9. 10.1001/jama.294.17.2203, 16264162.
26. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999, 319:670-4. 28218, 10480822.
27. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002, 287:2813-4. 10.1001/jama.287.21.2813, 12038920.
28. Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D, . CONSORT Group Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004, 141:781-8. CONSORT Group.
29. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Weyden MB. International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004, 364:911-2. 10.1016/S0140-6736(04)17034-7, 15364170.
30. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003, 326:1167-70. 10.1136/bmj.326.7400.1167, 156458, 12775614.
31. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF, . CONSORT Group CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008, 5:e20. 10.1371/journal.pmed.0050020, 2211558,2211558, 18215107, CONSORT Group.
32. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148:295-309.
33. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006, 144:364-7.
34. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, . CONSORT group Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008, 11(337):a2390. CONSORT group.